Navigation Links
Bausch + Lomb designa a Robert Bertolini presidente y CFO
Date:2/26/2013

ROCHESTER, Nueva York, 26 de febrero de 2013 /PRNewswire/ -- Bausch + Lomb, la compañía global dedicada a la salud visual, ha designado a Robert Bertolini presidente y CFO, nombramiento que entrará en vigencia inmediatamente. Como tal, supervisará las funciones de Finanzas, Tecnologías de la Información, y Calidad y Operaciones Globales (GQO, por sus siglas en inglés) de la compañía. Bertolini, quien asume las responsabilidades de Brian J. Harris como CFO, dependerá del CEO de Bausch + Lomb, Brent Saunders .

(Logo: http://photos.prnewswire.com/prnh/20121221/MM34011LOGO )

"La amplia experiencia estratégica, operativa y en liderazgo transformador de Bob Bertolini como CFO de una de las principales compañías dedicadas al cuidado de la salud que cotizan en bolsa posibilitarán que Bausch + Lomb continúe liberando nuestro potencial y acelerando nuestro rendimiento", dijo Saunders. "He tenido la oportunidad de trabajar codo a codo con Bob durante muchos años. Nos complace que un ejecutivo de su calibre se sume a nuestro equipo en este período central de nuestra historia".

La experiencia general y profundo conocimiento de Bertolini acerca de las operaciones y estrategias comerciales han posibilitado constantemente que las compañías en las que ha estado involucrado mejorasen su desempeño general y aumentasen sus resultados comerciales.

"Bajo el liderazgo de Brent, Bausch + Lomb ha hecho un inmenso progreso durante los últimos años, y espero con ansias trabajar con él y todo el equipo directivo de Bausch + Lomb para llevar la compañía al próximo
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bausch + Lomb Names John Barr Global President Surgical
2. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
3. Bausch + Lomb Commences Tender Offer of Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3 and U07190AA6)
4. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
5. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
6. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
7. Bausch + Lomb und CROMA spenden dringend benötigte Augentropfen
8. Bausch + Lomb Names Robert Bertolini President And Chief Financial Officer
9. Bausch + Lomb nomme Robert Bertolini président et directeur financier
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Delcath Systems, Inc. (Nasdaq: ... its proprietary Percutaneous Hepatic Perfusion ("PHP(TM)") System for ... today that Dr. James F. Pingpank will present ... Therapies, to be held February 21-23, 2009. ...
... Mass., Feb. 18 ,Abbott ( NYSE: ABT ) ... Hepatitis C (HCV) collaboration with a first-in-human study,evaluating ... of chronic,HCV. The objectives of the trial ... was discovered as part of a worldwide alliance,between ...
Cached Medicine Technology:Dr. James F. Pingpank to Present at Leading Regional Therapies Conference 2Dr. James F. Pingpank to Present at Leading Regional Therapies Conference 3Dr. James F. Pingpank to Present at Leading Regional Therapies Conference 4Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor 2Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor 3
(Date:9/1/2014)... 2014 (HealthDay News) -- You may be able to convince ... new research suggests. The study included eight overweight and ... program meant to change how people react to different foods. ... overweight and obese people who weren,t in the program. ... the study and again six months later. The scans revealed ...
(Date:9/1/2014)... Liver is the largest organ inside the human body. ... in barring itself from poisons, helps in digestion of food ... many important functions such as protein production, blood clotting and ... can affect the liver, an organ the size of a ... side of the abdomen, reducing its capabilities to perform its ...
(Date:9/1/2014)... 2014 An operating theatre or operating ... performing surgical operations. An operating room comprises a myriad ... operating room lights, imaging displays as well as integration ... Transparency Market Research, a U.S.-based market research firm, the ... 4.5 billion by 2019. , According to this ...
(Date:9/1/2014)... "Women struggle with weight gain typically ... begin as early as 15, if not earlier. ... ups and downs of hormone related weight gain. ... sizes seems to rage against the hidden and ever-present ... her 40's begin to face menopause and related changes, ...
(Date:9/1/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... American aid workers successfully cured a group of monkeys infected ... The drug, ZMapp, prompted recovery in all 18 monkeys who ... five days after infection. ZMapp even cured monkeys with ... away from death, said study senior author Gary Kobinger, chief ...
Breaking Medicine News(10 mins):Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 2Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 3Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3
... pill used for nerve pain offers women relief from hot ... the 45th Annual Meeting of the American Society ... decreased hot flash severity and frequency about 20 percent more ... about the same benefit as gabapentin, an older, related drug, ...
... EffortsSAN DIEGO, May 18 The Coalition for Pulmonary ... Thoracic Society,s (ATS) International conference in San Diego, Calif. ... together the world,s leading pulmonary, critical care and sleep ... partner grant program with ATS that, to date, has ...
... the disease is no more dangerous than regular flu , , ... swine flu continue to be no worse than seasonal flu, ... higher than that seen with seasonal flu, U.S. heath officials ... that the fatality [rate] is likely a little bit higher ...
... Bulletin Board: LTUS) ("Lotus" or the "Company") a company that ... today reported its financial results for the first quarter ended,March ... Highlights and Recent Developments:, -- Diluted EPS ... million, up 258% from first quarter 2008, ...
... is time for states to suspend, rather than terminate, ... say correctional health care experts from The Miriam Hospital ... of General Internal Medicine . , Although federal ... percent of states have implemented policies that withdraw inmates, ...
... - African-American women who were younger at menarche, or the ... a history of childhood sexual abuse, according to a new ... Center. The results suggest that a history of sexual abuse ... menstrual periods before age 12 years). , The study, which ...
Cached Medicine News:Health News:Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes 2Health News:Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes 3Health News:Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes 4Health News:Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference 2Health News:Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference 3Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 2Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 3Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 4Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 5Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 6Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 7Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 8Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 9Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 10Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 11Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 12Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 13Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 2Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 3Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 4Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 5Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 6Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 7Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 8Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 9Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 10Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 11Health News:Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 12Health News:Filling the gap: The importance of Medicaid continuity for former inmates 2Health News:Study finds higher prevalence of early menarche among survivors of childhood sexual abuse 2
... IMMULITE 1000 assays are designed ... and IMMULITE 1000, continuous random ... simplicity in both design and ... found in a wide variety ...
... (DHEA-S) is the sulfate ester of DHEA, ... conversion of DHEA in adrenal and extradrenal ... secreted by the adrenal cortex, and is ... DHEA possesses relatively weak androgenic activity, which ...
125I radioimmunoassay, Simple extraction procedure, Ready-to-use calibrators, Less than 0.1% crossreactivity with DHEA-SO4, 2-hour single incubation, 37C, Calibration Range: 0.5 30 ng/mL...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM....
Medicine Products: